top of page
.png)
Cell and Gene Therapy Updates
April 3rd & 4th, 2025 Regulatory Updates 🎯 The UK MHRA granted conditional marketing authorization for Autolus Therapeutics ’...
Oncofocus Team
Jun 20, 20252 min read
Cell and Gene Therapy Updates
April 2nd April, 2025 ⭐ Regulatory Events 🎯 The US FDA cleared an IND application of CERo Therapeutics, Inc. ’s CER-1236 (anti-Tim-4L...
Oncofocus Team
Jun 20, 20251 min read
Cell and Gene Therapy Updates
March 3rd Week, 2025 Regulatory Events 🎯 The European commission granted approval to Bristol Myers Squibb ’ Breyanzi (lisocabtagene...
Oncofocus Team
Jun 20, 20252 min read
Cell and Gene Therapy Updates
March 1st Week, 2025 ⭐ Regulatory Events 🎯 China’s NMPA granted Breakthrough Therapy Designation (BTD) to CARsgen Therapeutics ’...
Oncofocus Team
Jun 20, 20251 min read
Cell and Gene Therapy Updates
February 4th Week, 2025 📝 The US FDA granted RMAT designation for ImmunityBio ’s Anktiva (n ogapendekin alfa inbakicept; IL-15...
Oncofocus Team
Jun 20, 20251 min read
Cell and Gene Therapy Updates
February 3rd Week, 2025 📝 BMS’ Breyanzi (liso-cel; an autologous, anti-CD19 CAR-T) received NICE recommendation as an option for...
Oncofocus Team
Jun 20, 20251 min read
bottom of page